Here, we report a novel zebrafish transgenic line expressing the SBDSR126T mutation under the ubiquitin (ubi) promoter that in high doses (2x copies of the transgene) rescued the sbds KO early mortality and neutropenia but did not abrogate activation of the tp53/cdkn1a pathway. This evidence concerns the gene TP53 and neutropenia.